Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

It is unclear whether use of contemporary protease inhibitors pose a similar risk of chronic kidney disease (CKD) as use of older protease inhibitors. Participants in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study were followed up until the earliest occurrence of CKD, the last...

Full description

Saved in:

Bibliographic Details
Published in:	The Journal of infectious diseases Vol. 220; no. 10; p. 1629
Main Authors:	Ryom, Lene, Dilling Lundgren, Jens, Reiss, Peter, Kirk, Ole, Law, Matthew, Ross, Mike, Morlat, Phillip, Andreas Fux, Christoph, Fontas, Eric, De Wit, Stephane, D'Arminio Monforte, Antonella, El-Sadr, Wafaa, Phillips, Andrew, Ingrid Hatleberg, Camilla, Sabin, Caroline, Mocroft, Amanda
Format:	Journal Article
Language:	English
Published:	United States 08.10.2019
Subjects:	Adult Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Female Follow-Up Studies HIV Infections - complications HIV Infections - drug therapy HIV Protease Inhibitors - adverse effects HIV Protease Inhibitors - therapeutic use Humans Incidence Male Middle Aged Prospective Studies Renal Insufficiency, Chronic - chemically induced Renal Insufficiency, Chronic - epidemiology Risk Assessment HIV nephrotoxicity atazanavir protease inhibitors adverse drug effect darunavir CKD
ISSN:	1537-6613, 1537-6613
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!